Muntendam Pieter 4
4 · BG Medicine, Inc. · Filed Jun 11, 2012
Insider Transaction Report
Form 4
Muntendam Pieter
DirectorPresident, CEO
Transactions
- Sale
Common Stock
2012-06-08$5.29/sh−3,965$20,975→ 78,483 total - Sale
Common Stock
2012-06-07$5.50/sh−30,021$165,116→ 82,448 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.65, inclusive. The reporting person undertakes to provide to BG Medicine, Inc., any security holder of BG Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.50, inclusive.